VAN ECK ASSOCIATES CORP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 6 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$34
-20.9%
6790.0%0.00%
Q2 2023$43
+16.2%
679
-17.7%
0.00%
Q1 2023$37
-14.0%
825
-16.3%
0.00%
Q4 2022$43
-99.9%
986
+51.2%
0.00%
Q3 2022$43,000
-56.6%
652
-57.9%
0.00%
Q1 2022$99,000
-30.8%
1,548
+16.0%
0.00%
Q4 2021$143,000
+20.2%
1,335
+15.2%
0.00%
Q3 2021$119,000
+85.9%
1,159
+59.2%
0.00%
Q2 2021$64,000
+93.9%
728
+116.7%
0.00%
Q1 2021$33,0003360.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders